Drug-price Transparency for Consumers Act of 2023
USA118th CongressHR-5958| House
| Updated: 12/17/2024
Abigail Davis Spanberger
Democratic Representative
Virginia
Cosponsors (1)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
Administrative law and regulatory proceduresCivil actions and liabilityDepartment of Health and Human ServicesHealth care costs and insuranceMarketing and advertisingPrescription drugs
Drug-price Transparency for Consumers Act of 2023
USA118th CongressHR-5958| House
| Updated: 12/17/2024
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Abigail Davis Spanberger
Democratic Representative
Virginia
Cosponsors (1)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresCivil actions and liabilityDepartment of Health and Human ServicesHealth care costs and insuranceMarketing and advertisingPrescription drugs